Celebrating Innovation and Impact
July 14, 2024
Reprinted from Blacktown News with thanks:
Since its inception, Western Sydney Diabetes has been at the forefront of innovative diabetes management strategies, making a remarkable impact on the lives of those living with this condition.
A Game-Changer: Continuous Glucose Monitoring (CGM)
One of the most groundbreaking advancements embraced by the WSD team is Continuous Glucose Monitoring (CGM). WSD was an early adopter, integrating CGM into its specialist services for people with type 2 diabetes referred by their GPs. This technology has proven to be a game-changer in diabetes care.
How CGM Works and Its Benefits:
- CGM measures glucose levels continuously throughout the day and night using a small sensor placed on the skin.
- This eliminates the need for frequent finger pricks, providing a more comprehensive view of glucose trends.
- With real-time data, patients and healthcare providers can make precise medication adjustments and lifestyle recommendations.
- Studies have shown the transformative power of CGM. Combined with GP virtual case conferencing, it has revolutionized diabetes management.
WSD’s Success with CGM:
- WSD patients have experienced an average HbA1C reduction of 1.4% and an increase in Time in Range from 46% to 73% within just 3 to 6 months.
- Additionally, the incidence of hypoglycemia has notably decreased, enhancing overall patient safety and well-being.
The Challenge of Accessibility:
While CGM is incredibly beneficial, it’s not yet widely accessible to everyone with type 2 diabetes. In Western Sydney alone, nearly 13% of adults live with type 2 diabetes, and 38% are at high risk. Managing diabetes costs over $18,000 per patient annually, totaling $1.8 billion in our region. By subsidizing CGM, health outcomes could improve and reduce these staggering costs.
Learn More and Get Involved:
- Residents are invited to visit the WSD website to read patient stories and learn more about the impact of CGM.
- The diabetes challenge is a community effort. Join the cause in spreading the word and supporting this innovative technology.
Dr. Rajini Jayaballa, Senior Lecturer at Macquarie University, emphasizes the importance of CGM: “CGM is a vital tool in the mission to improving the lives of those with diabetes. We look forward to a future where it is accessible to all patients with type 2 diabetes.”